|Title||A multicenter, Open-Label, Non-Randomized Study to Assess the Tolerability and Safety of a Single, Subcutaneous Administration of Ecallantide in Children and Adolescents with Hereditary Angioedema|
|Summary||The purpose of this clinical research study to test how well and how safe an investigational medication works in children and adolescent with HAE|
|Description||NYU Winthrop Hospital, Clinical Trials Center is conducting this clinical research study for children and adolescents, ages 2- 15 years old who have been diagnosed with Hereditary Angioedema (swelling of the skin, abdomen and/or face and throat which occur repeatedly).
Eligible participants will receive study-related medical examinations, research medication and laboratory tests at no cost to you, during your participation in this research study. Compensation may also be provided for time and travel.
|Inclusion/Notes||To be eligible for the study, you must;
|Principal Name||Mark Davis-Lorton, MD|
|Contact Name||NYU Winthrop Hospital - Clinical Trials Center|